Concluding remarks.
作者信息
Glassock Richard J
机构信息
The David Geffen School of Medicine at UCLA, Los Angeles, Calif., USA.
出版信息
Contrib Nephrol. 2007;157:169-73. doi: 10.1159/000102463.
PMID:17495458
Abstract
摘要
相似文献
1
Concluding remarks.
Contrib Nephrol. 2007;157:169-73. doi: 10.1159/000102463.
2
IgA nephropathy: recent developments.
J Am Soc Nephrol. 2000 Dec;11(12):2395-2403. doi: 10.1681/ASN.V11122395.
3
IgA nephropathy: what's new?
Pediatr Nephrol. 2007 Nov;22(11):1809-14. doi: 10.1007/s00467-007-0515-1. Epub 2007 Jul 10.
4
New therapeutic approaches in primary IgA nephropathy.
Adv Nephrol Necker Hosp. 1999;29:73-91.
5
Treatment of IgA nephropathy.
Springer Semin Immunopathol. 1994;16(1):121-7. doi: 10.1007/BF00196719.
6
[Prognostic factors in IgA nephropathy: what's new?].
G Ital Nefrol. 2009 Sep-Oct;26(5):559.
7
Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis--is it the only cause?
Nephrol Dial Transplant. 2007 Oct;22(10):3079-81. doi: 10.1093/ndt/gfm506. Epub 2007 Jul 27.
8
[Summary of the 11th national conference of pediatric nephrology].
Zhonghua Er Ke Za Zhi. 2003 Feb;41(2):116-8.
9
[Historical remarks on nephrology research in Japan. 2. Clinical research on nephritis and renal biology(discussion)].
Nihon Jinzo Gakkai Shi. 2002 Dec;44(8):762-78.
10
[JSN and MHLW Clinical Practice Guidelines for IgA nephropathy 2014].
Nihon Jinzo Gakkai Shi. 2015;57(1):5-137.
引用本文的文献
1
A Rare Genetic Defect of Increased the Risk for Progression of IgA Nephropathy.
Front Immunol. 2019 Mar 22;10:537. doi: 10.3389/fimmu.2019.00537. eCollection 2019.
2
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
Semin Nephrol. 2008 Jan;28(1):78-87. doi: 10.1016/j.semnephrol.2007.10.009.
Zotero 插件